Literature DB >> 11325928

Cloning and functional characterization of an NAD(+)-dependent DNA ligase from Staphylococcus aureus.

F S Kaczmarek1, R P Zaniewski, T D Gootz, D E Danley, M N Mansour, M Griffor, A V Kamath, M Cronan, J Mueller, D Sun, P K Martin, B Benton, L McDowell, D Biek, M B Schmid.   

Abstract

A Staphylococcus aureus mutant conditionally defective in DNA ligase was identified by isolation of complementing plasmid clones that encode the S. aureus ligA gene. Orthologues of the putative S. aureus NAD(+)-dependent DNA ligase could be identified in the genomes of Bacillus stearothermophilus and other gram-positive bacteria and confirmed the presence of four conserved amino acid motifs, including motif I, KXDG with lysine 112, which is believed to be the proposed site of adenylation. DNA sequence comparison of the ligA genes from wild type and temperature-sensitive S. aureus strain NT64 identified a single base alteration that is predicted to result in the amino acid substitution E46G. The S. aureus ligA gene was cloned and overexpressed in Escherichia coli, and the enzyme was purified to near homogeneity. NAD(+)-dependent DNA ligase activity was demonstrated with the purified enzyme by measuring ligation of (32)P-labeled 30-mer and 29-mer oligonucleotides annealed to a complementary strand of DNA. Limited proteolysis of purified S. aureus DNA ligase by thermolysin produced products with apparent molecular masses of 40, 22, and 21 kDa. The fragments were purified and characterized by N-terminal sequencing and mass analysis. The N-terminal fragment (40 kDa) was found to be fully adenylated. A fragment from residues 1 to 315 was expressed as a His-tagged fusion in E. coli and purified for functional analysis. Following deadenylation with nicotinamide mononucleotide, the purified fragment could self-adenylate but lacked detectable DNA binding activity. The 21- and 22-kDa C-terminal fragments, which lacked the last 76 amino acids of the DNA ligase, had no adenylation activity or DNA binding activity. The intact 30-kDa C terminus of the S. aureus LigA protein expressed in E. coli did demonstrate DNA binding activity. These observations suggest that, as in the case with the NAD(+)-dependent DNA ligase from B. stearothermophilus, two independent functional domains exist in S. aureus DNA ligase, consisting of separate adenylation and DNA binding activities. They also demonstrate a role for the extreme C terminus of the ligase in DNA binding. As there is much evidence to suggest that DNA ligase is essential for bacterial survival, its discovery in the important human pathogen S. aureus indicates its potential as a broad-spectrum antibacterial target for the identification of novel antibiotics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325928      PMCID: PMC95200          DOI: 10.1128/JB.183.10.3016-3024.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  30 in total

1.  Role in cell permeability of an essential two-component system in Staphylococcus aureus.

Authors:  P K Martin; T Li; D Sun; D P Biek; M B Schmid
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

2.  Crystal structure of NAD(+)-dependent DNA ligase: modular architecture and functional implications.

Authors:  J Y Lee; C Chang; H K Song; J Moon; J K Yang; H K Kim; S T Kwon; S W Suh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

3.  Modification of Escherichia coli DNA ligase by cleavage with trypsin.

Authors:  S M Panasenko; P Modrich; I R Lehman
Journal:  J Biol Chem       Date:  1976-06-10       Impact factor: 5.157

4.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  Conditional-lethal deoxyribonucleic acid ligase mutant of Escherichia coli.

Authors:  J J Dermody; G T Robinson; R Sternglanz
Journal:  J Bacteriol       Date:  1979-08       Impact factor: 3.490

6.  Deoxyribonucleic acid ligase. A steady state kinetic analysis of the reaction catalyzed by the enzyme from Escherichia coli.

Authors:  P Modorich; I R Lehman
Journal:  J Biol Chem       Date:  1973-11-10       Impact factor: 5.157

7.  Deoxyribonucleic acid ligase. Isolation and physical characterization of the homogeneous enzyme from Escherichia coli.

Authors:  P Modrich; Y Anraku; I R Lehman
Journal:  J Biol Chem       Date:  1973-11-10       Impact factor: 5.157

8.  Nucleotide sequence and functional map of pE194, a plasmid that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibodies.

Authors:  S Horinouchi; B Weisblum
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

9.  Macromolecular crowding allows blunt-end ligation by DNA ligases from rat liver or Escherichia coli.

Authors:  S B Zimmerman; B H Pheiffer
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Eukaryotic DNA ligase. Purification and properties of the enzyme from bovine thymus, and immunochemical studies of the enzyme from animal tissues.

Authors:  H Teraoka; K Tsukada
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

View more
  17 in total

1.  Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.

Authors:  Scott D Mills; Ann E Eakin; Ed T Buurman; Joseph V Newman; Ning Gao; Hoan Huynh; Kenneth D Johnson; Sushmita Lahiri; Adam B Shapiro; Grant K Walkup; Wei Yang; Suzanne S Stokes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Structure-guided Mutational Analysis of the Nucleotidyltransferase Domain of Escherichia coli DNA Ligase (LigA).

Authors:  Li Kai Wang; Hui Zhu; Stewart Shuman
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

3.  In vitro and in vivo validation of ligA and tarI as essential targets in Staphylococcus aureus.

Authors:  Karin Streker; Tina Schäfer; Christoph Freiberg; Heike Brötz-Oesterhelt; Jörg Hacker; Harald Labischinski; Knut Ohlsen
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

4.  Homology modeling of NAD+-dependent DNA ligase of the Wolbachia endosymbiont of Brugia malayi and its drug target potential using dispiro-cycloalkanones.

Authors:  Nidhi Shrivastava; Jeetendra K Nag; Jyoti Pandey; Rama Pati Tripathi; Priyanka Shah; Mohammad Imran Siddiqi; Shailja Misra-Bhattacharya
Journal:  Antimicrob Agents Chemother       Date:  2015-04-06       Impact factor: 5.191

5.  Virtual screening of specific chemical compounds by exploring E.coli NAD+-dependent DNA ligase as a target for antibacterial drug discovery.

Authors:  Bashir Akhlaq Akhoon; Shishir K Gupta; Gagan Dhaliwal; Mugdha Srivastava; Shailendra K Gupta
Journal:  J Mol Model       Date:  2010-05-05       Impact factor: 1.810

6.  Discovery and design of DNA and RNA ligase inhibitors in infectious microorganisms.

Authors:  Robert V Swift; Rommie E Amaro
Journal:  Expert Opin Drug Discov       Date:  2009-12-01       Impact factor: 6.098

7.  A second NAD(+)-dependent DNA ligase (LigB) in Escherichia coli.

Authors:  V Sriskanda; S Shuman
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

8.  Structure of the adenylation domain of NAD(+)-dependent DNA ligase from Staphylococcus aureus.

Authors:  Seungil Han; Jeanne S Chang; Matt Griffor
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-10-13

9.  Staphylococcus aureus DNA ligase: characterization of its kinetics of catalysis and development of a high-throughput screening compatible chemiluminescent hybridization protection assay.

Authors:  Sheraz Gul; Richard Brown; Earl May; Marie Mazzulla; Martin G Smyth; Colin Berry; Andrew Morby; David J Powell
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

10.  Structure-guided mutational analysis of the OB, HhH, and BRCT domains of Escherichia coli DNA ligase.

Authors:  Li Kai Wang; Pravin A Nair; Stewart Shuman
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.